GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (NAS:AMED) » Definitions » Cyclically Adjusted Price-to-FCF

AMED (Amedisys) Cyclically Adjusted Price-to-FCF : 16.96 (As of Jun. 03, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Amedisys Cyclically Adjusted Price-to-FCF?

As of today (2025-06-03), Amedisys's current share price is $94.49. Amedisys's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $5.57. Amedisys's Cyclically Adjusted Price-to-FCF for today is 16.96.

The historical rank and industry rank for Amedisys's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

AMED' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.29   Med: 21.54   Max: 95.88
Current: 16.98

During the past years, Amedisys's highest Cyclically Adjusted Price-to-FCF was 95.88. The lowest was 11.29. And the median was 21.54.

AMED's Cyclically Adjusted Price-to-FCF is ranked better than
53.89% of 193 companies
in the Healthcare Providers & Services industry
Industry Median: 19.89 vs AMED: 16.98

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Amedisys's adjusted free cash flow per share data for the three months ended in Mar. 2025 was $-0.154. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $5.57 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Amedisys Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Amedisys's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys Cyclically Adjusted Price-to-FCF Chart

Amedisys Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.61 44.26 19.92 21.29 16.33

Amedisys Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.18 17.92 18.02 16.33 16.64

Competitive Comparison of Amedisys's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, Amedisys's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amedisys's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Amedisys's Cyclically Adjusted Price-to-FCF falls into.


;
;

Amedisys Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Amedisys's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=94.49/5.57
=16.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amedisys's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Amedisys's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.154/134.9266*134.9266
=-0.154

Current CPI (Mar. 2025) = 134.9266.

Amedisys Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.837 100.684 1.122
201509 0.874 100.392 1.175
201512 0.500 99.792 0.676
201603 0.165 100.470 0.222
201606 0.339 101.688 0.450
201609 0.095 101.861 0.126
201612 0.778 101.863 1.031
201703 0.667 102.862 0.875
201706 0.967 103.349 1.262
201709 0.250 104.136 0.324
201712 0.887 104.011 1.151
201803 1.123 105.290 1.439
201806 1.478 106.317 1.876
201809 1.970 106.507 2.496
201812 1.921 105.998 2.445
201903 0.573 107.251 0.721
201906 1.754 108.070 2.190
201909 1.328 108.329 1.654
201912 2.224 108.420 2.768
202003 0.138 108.902 0.171
202006 4.015 108.767 4.981
202009 2.459 109.815 3.021
202012 1.911 109.897 2.346
202103 1.578 111.754 1.905
202106 2.020 114.631 2.378
202109 1.805 115.734 2.104
202112 0.115 117.630 0.132
202203 1.449 121.301 1.612
202206 1.689 125.017 1.823
202209 -0.474 125.227 -0.511
202212 1.193 125.222 1.285
202303 0.748 127.348 0.793
202306 1.624 128.729 1.702
202309 -0.336 129.860 -0.349
202312 1.784 129.419 1.860
202403 -0.286 131.776 -0.293
202406 1.535 132.554 1.562
202409 3.140 133.029 3.185
202412 2.081 133.157 2.109
202503 -0.154 134.927 -0.154

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Amedisys  (NAS:AMED) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Amedisys Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Amedisys's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Amedisys Business Description

Traded in Other Exchanges
N/A
Address
3854 American Way, Suite A, Baton Rouge, LA, USA, 70816
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Executives
Allyson Guidroz officer: Chief Accounting Officer 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard M Ashworth director, officer: President and CEO 200 WILMOT ROAD, DEERFIELD IL 60015
Michael Paul North officer: Chief Information Officer 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Adam Y Holton officer: Chief People Officer C/O CHS INC., 5500 CENEX DRIVE, INVER GROVE HEIGHTS MN 55077
Denise M. Bohnert officer: Chief Compliance Officer 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Nick Muscato officer: Chief Strategy Officer 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Richard A Lechleiter director PO BOX 32890, LOUISVILLE KY 40232-2890
Bruce D Perkins director 500 WEST MAIN STREET, LOUISVILLE KY 40202
Christopher Gerard officer: Chief Operating Officer 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Teresa L. Kline director C/O INTERSECT ENT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025
Jeffrey A Rideout director 2142 DEER OAK WAY, DANVILLE CA 94506
Julie D Klapstein director 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
David L Kemmerly officer: See Remarks 3854 AMERICAN WAY, SUITE A, BATON ROUGE LA 70816

Amedisys Headlines